Immunosuppression following thermal injury: The pathogenesis of immunodysfunction

British Journal of Plastic Surgery

Volumn 50, Issue 8, 1997, Pages 615-623

  O'Sullivan, S T ^a,b   O'Connor, T P F ^a  

^a Cork University Hospital ^*  (Ireland)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYTOKINE; ENDOTOXIN; GROWTH FACTOR;

B LYMPHOCYTE; CELLULAR IMMUNITY; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; LUNG BURN; MACROPHAGE; METABOLIC REGULATION; MONOCYTE; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; THERMAL INJURY;

EID: 0031455122     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-1226(97)90507-5     Document Type: Review

References (119)

1. Baker CC, Oppenheimer L, Stephans B, Lewis FR, Trunkey DD. Epidemiology of trauma deaths. Am J Surg 1980; 140: 144-50.
2. Demling RH, LaLonde C, Saldinger P, Knox J. Multiple organ dysfunction in the surgical patient: Pathophysiology, prevention and treatment. Curr Probl Surg 1993; 30: 347-414.
3. Donati L, Lazzarin A, Signorini A, et al. Preliminary experience with the use of immunomodulating drugs in burns. J Trauma 1983; 23: 816-31.
4. Shirani KZ, Pruitt BA Jr, Mason AD Jr. The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 1987; 205: 82-7.
5. Alexander JW, Meakins J. A physiological basis for the development of opportunistic infections in man. Arch Surg 1972; 176: 273-87.
6. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222: 482-92.
7. Mannick JA, Trauma, sepsis and immune defects. In: Host defense dysfunction in trauma, shock and sepsis. Faist E. Meakins J & Schildberg FW, eds. 1993, Springer Verlag, Berlin/Heidelberg, Germany, 15-21.
8. Wood JJ, Rodrick ML, O'Mahoney JB, Mannick JA. Inadequate interleukin 2 production: A fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200: 311-20.
9. Rodrick ML, Wood JJ, O'Mahony JB, et al. Mechanisms of immunosuppression associated with severe non-thermal traumatic injuries in man: Production of interleukin 1 and 2. J Clin Immunol 1986; 6: 310-8.
10. Takayama TK, Miller C, Szabo G. Elevated tumor necrosis factor α production concomitant to elevated prostaglandin E, production by trauma patients' monocytes. Arch Surg 1990; 125; 29-35.
11. Herndon DN, Traber DL, Niehaus GD, Linares HA, Traber LD. The pathophysiology of smoke inhalation in a sheep model. J Trauma 1984; 24: 1044-51.
12. Herndon DN, Adams TJ, Traber LD, Traber DL. Inhalation injury and positive pressure ventilation in a sheep model. Circ Shock 1984; 12: 107-13.
13. Birky MM, Clarke FB. Inhalation of toxic products from fires. Bull N Y Acad Med 1981; 57: 997-1013
14. Traber DL, Pollard V. Pathophysiology of inhalation injury. In: Total Burn Care. DN Herndon, ed. 1996 WB Saunders, London, 175-83.
15. LaLonde C, Knox J, Youn YK, Demling R. Burn edema is accentuated by a moderate smoke inhalation injury in sheep. Surgery 1992; 112: 908-17.
16. Montero K, Lubbesmeyer HJ, Traber DL, Kimura R, Traber LD, Herndon DN. Inhalation injury increases systemic vascular microvascular permeability. Surg Forum 1987; 38: 303-5.
17. Sugi K, Theissen JL, Traber LD, Herndon DN, Traber DL. Impact of carbon monoxide on cardiopulmonary dysfunction after smoke inhalation injury. Circ Res 1990; 66: 69-75.
18. Quinn DA, Robinson D, Jung W, Hales CA. Role of sulfidopeptide leukotrienes in synthetic smoke inhalation injury in sheep. J Appl Physiol 1990; 68: 1962-9.
19. Morris SE, Navaratnam N, Townsend CM Jr, Herndon DN. Bacterial translocation and mesenteric blood flow in a large animal model after cutaneous thermal and smoke inhalation injury. Surg Forum 1988; 39: 189-90.
20. Lundberg JM, Saria A. Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiol Scand 1982; 116: 473-6.
21. O'Sullivan ST, Horgan AF, Chin DHL, Wolf SF, Rodrick ML, Mannick JA. Synergy between IL-2 and IL-12 restores normal T cell and natural killer cell function after thermal injury. Presented at meeting of European Burns Association, September 1995, Verona, Italy.
22. O'Suilleabhain CB, O'Sullivan ST, Kelly JL, Lederer JA, Mannick JA, Rodrick ML. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996; 120: 290-6.
23. Blazar BA, Rodrick ML, O'Mahony JB et al. Suppression of natural killer cell function in man following thermal and traumatic injury. J Clin Immunol 1986; 6: 26-36.
24. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
25. Barton R, Cerra F. The hypermetabolism multiple organ failure syndrome. Chest 1989; 96: 1153-8.
26. Crump J, Duncan D, Wears R. Analysis of multiple organ system failure in trauma and non-trauma patients. Ann Surg 1988; 54: 702-8.
27. Pinsky M, Matuschak G. A unifying hypothesis of multiple systems organ failure: Failure of host defense homeostasis. J Crit Care 1990; 5: 108-14.
28. Schmand JF, Ayala A, Chaudry IH. Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med 1994; 22: 1076-83.
29. Gough DB, Moss NM, Jordan A, Grbic JT, Rodrick ML. Mannick JA. Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery 1988; 104: 292-300.
30. Horgan PG, Mannick JA, Dubravec DB, Rodrick ML. Effect of low dose recombinant interleukin 2 plus indomethacin on mortality after sepsis in a murine burn model. Br J Surg 1990; 77: 401-4.
31. Alexander JW. Mechanism of immunologic suppression in burn injury. J Trauma 1990; 30: S70-S75.
32. Hinder F, Traber DL. Pathyphysiology of the systemic inflammatory response syndrome. In: Total Burn Care, Herndon DN ed. 1996 WB Saunders, London, 207-16.
33. Fong Y, Moldawer L, Shires T, et al. The biologic characteristics of cytokines and their implications in surgical injury. Surg Gynecol Obstet 1990; 170: 363-78.
34. Takeda K, Shimada Y, Amano M, et al. Plasma lipid peroxides and alpha tocopherol in critically ill patients. Crit Care Med 1984; 17: 489-93.
35. Demling R. Role of mediators in human ARDS. J Crit Care 1988; 3: 56-72.
36. Dobke MK, Simoni J, Ninnemann JL, Garrett J, Harner TJ. Endotoxemia after burn injury: Effect of early excision on circulation endotoxin levels. J Burn Care Rehabil 1989; 10: 107-11.
37. Munster AM, Smith-Meek M, Dickerson C, Weinchurch RA. Translocation: Incidental phenomenon or true pathology? Ann Surg 1993; 218: 321-7.
38. Baron P, Traber LD, Traber DL, Nguyen T, Hollyoak M, Heggers JP, Herndon DN. Gut failure and translocation following burn and sepsis. J Surg Res 1994; 57: 197-204.
39. Deitch EA, Berg RD. Endotoxin but not malnutrition promotes bacterial translocation of the gut flora in burned mice. J Trauma 1987; 27: 161-6.
40. Jones WG, Minei JP, Barber AE, Rayburn JL, Fahey TJ, Shires GT. Bacterial translocation and intestinal atrophy after thermal injury and burn wound sepsis. Ann Surg 1990; 211: 399-405.
41. Maejima K, Deitch E, Berg R. Promotion by burn stress of the translocation of bacteria from the gastrointestinal tract of mice. Arch Surg 1984; 119: 166-72.
42. Moran KT, Munster AM. Alterations of the host defense mechanism in burned patients. Surg Clin North Am 1987; 67: 47-55.
43. Munster AM. The immunological response and strategies for intervention. In: Total Burn Care, Herndon DN ed. 1996 WB Saunders, London, 279-92.
44. Zhong W, Hand T, Burke P, Forse RA. Human macrophage cytokine gene regulation to endotoxin is both dose and time dependent. Surg Inf Soc Prog 1992; 12: 38
45. de Groote MA, Martin MA, Denesen P, et al. Plasma tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg 1991; 126: 231-5.
46. Hoffman WD, Natanson C. Endotoxin in septic shock. Anesth Analg 1993; 77: 613-24.
47. Reines D, Cook J. Prostaglandins. In: Multiple system organ failure. Fry D, ed. 1992 CV Mosby, St. Louis, 123-39.
48. Sheridan RL, Tompkins RG. Etiology and prevention of multisystem organ failure. In: Total burn care. Herndon DN ed. 1996 WB Saunders, London, 302-312.
49. 2 in immune suppression following injury. Ann Surg 1991; 214: 253-63.
50. Horgan AF, Mendez MV, O'Riordain DS, Holzheimer RG, Mannick JA, Rodrick ML. Altered gene transcription after burn injury results in depressed T lymphocyte activation. Ann Surg 1994; 220: 342-52.
51. Whittle BJ, Moncada S. Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 1983; 39: 232-8.
52. Sprague RS, Stephenson AH, Dahms TE, Lonigro AJ. Proposed role for leukotrienes in the pathophysiology of multiple systems organ failure. Crit Care Clin 1989; 5: 315-29.
53. Lewis RA, Austen KF. The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions and pharmacology. J Clin Invest 1984; 73: 889-97.
54. Regan MC, Barbul A. The role of the wound in post-traumatic immune dysfunction. 1989 In: Faist E, Meakins J, Schildberg FW. Host defense dysfunction in trauma, shock and sepsis. Springer-Verlag, Berlin, Heidelberg, Germany, 1043-9.
55. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson M. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993; 19: 401-5.
56. Bridges M, Morris D, Hall JR, Deitch EA. Effects of wound exudates on in vitro immune parameters. J Surg Res 1987; 43: 133-5.
57. Deitch EA, Smith BJ. The effect of blister fluid from thermally injured patients on normal lymphocyte transformation. J Trauma 1983; 23: 106-10.
58. Barbul A, Fishel RS, Shimazu S, Damewood RB, Wasserkrug HL, Efron G. Inhibition of host immunity by fluid and mononuclear cells from healing wounds. Surgery 1984; 96: 315-9.
59. Shimazu S. Elevation of immunosuppressive properties of fluid from healing wounds. Nippon Geka Gakkai Zasshi 1987; 88: 1667-75.
60. Lazarou SA, Barbul A, Wasserkrug HL, Efron G. The wound as a possible source of post-traumatic immunosuppression. Arch Surg 1989; 124: 1429-31.
61. Takayama TK, Miller C, Szabo G. Elevated tumor necrosis factor α production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes. Arch Surg 1990; 125: 29-35.
62. Stephan RN, Ayala A, Harkema JM, Dean RE, Border JR, Chaudry IH. Mechanism of immunosuppression following hemorrhage: Defective antigen presentation by monocytes. J Surg Res 1989; 46: 553-6.
63. Solomkin JS, Cotta LA, Ogle JD, et al. Complement-induced expression of cryptic receptors on the neutrophil surface: A mechanism for regulation of acute inflammation in trauma. Surgery 1984; 96: 336-44.
64. O'Mahony JB, Wood JJ, Rodrick ML, Mannick JA. Changes in T lymphocyte subsets following injury: Assessment by flow cytometry and relationship to sepsis. Ann Surg 1985; 202: 580-6.
65. O'Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH, Mannick JA. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24: 869-75.
66. Hansbrough JF, Peterson V, Kortz E, Piacentine JG. Postburn immunosuppression in an animal model: Monocyte dysfunction induced by burn tissue. Surgery 1983; 93: 415-23.
67. 2-dependent suppression of interleukin á(IL-2) production in patients with major trauma. J Trauma 1987; 27: 837-48.
68. Unanue ER, Beller DI, Lu CY, Allen PM. Antigen presentation: Comments on its recognition and mechanism. J Immunol 1984; 132: 1-7.
69. Snyder DS, Beller DI, Unanue ER. Prostaglandins modulate macrophage la expression. Nature 1982; 299: 163-5.
70. Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 1993; 80: 289-97.
71. Rodrick ML, Moss NM, Grbic JT, et al. Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol 1992; 12: 440-50.
72. O'Riordain DS, Mendez MV, O'Riordain MG, et al. Molecular mechanisms of decreased interleukin-2 production after thermal injury. Surgery 1993; 114: 407-14.
73. Mendez MV, Molloy RG, O'Riordain DS, et al. Lymphokine-activated killer cells enhance IL-2 prevention of sepsis-related death in a murine model of thermal injury. J Surg Res 1993; 54: 565-70.
74. Drost AC, Burleson DG, Cioffi WG, Mason AD, Pruitt BA. Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 1993; 218: 74-8.
75. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984; 311: 1413-18.
76. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; i: 355-7.
77. Luger A, Graf H, Scharz H, et al. Decreased serum interleukin-1 activity and monocyte interleukin-1 production in patients with fatal sepsis. Crit Care Med 1986; 14: 458-61.
78. Starnes HF, Pearce MK, Tewari A, et al. Anti-IL-6 monoclonal antibodies protect against lethal E. coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol 1990; 145: 4185-91.
79. Dinarello CA. The proinflammatory cytokines, interleukin-1 and tumor necrosis factor and the treatment of the septic shock syndrome. J Infect Dis 1991; 163: 1177-84.
80. Sugarman BJ, Aggarwal BB, Hass PE, et al. Recombinant tumor necrosis factor a: Effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943-5.
81. Dayer JM, De Rochemonteix B, Burrus B, et al. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E, production by human synovial cells. J Clin Invest 1986; 77: 645-8.
82. Marano MA, Fong Y, Moldawer LL, et al. Serum cachectin/ tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990; 170: 32-8.
83. Exley AR, Cohen J, Buurman W, et al. Monoclonal antibody to TNF in severe septic shock. Lancet 1990; 335: 1275-7.
84. Burleson DG, Mason AD, Pruitt BA. Lymphoid subpopulation changes after thermal injury and thermal injury with infection in an experimental model. Ann Surg 1988; 207: 208-12.
85. Organ BC, Antonacci AC, Chiao J, et al. Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury. Ann Surg 1988; 207: 208-12.
86. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 1996; 138-46.
87. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14: 335-7.
88. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes - an autoregulatory role of 11-10 produced by monocytes. J Exp Med 1991; 174: 1209-20.
89. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
90. Kobayachi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989; 170: 827-45.
91. Hseih CS, Macatonio SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4 + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547-8.
92. Miller-Graziano CL, Szabo G, Griffey K, Metha B, Kodys K, Catalano D. Role of elevated transforming growth factor β (TGFβ) production in posttrauma immunosuppression. J Clin Immunol 1991; 11: 95-102.
93. Muller MJ, Gilpin DA, Herndon DN. Modulation of wound healing and the postburn response. In: Total burn care. Herndon DN ed. 1996, WB Saunders, London, 223-36.
94. Becker RA, Vaughan GM, Goodwin CW, et al. Interactions of thyroid hormones and catecholamines in severely burned patients. Rev Infect Dis 1983; 5: S908-S913.
95. Aun F, Medeiros-Neto GA, Younes RN, Birogini D, Ramos de Oliveira M. The effect of major trauma on the pathways of thyroid hormone metabolism. J Trauma 1983; 23: 1048-50.
96. Gelfand RA, Hutchinson-Williams KA, Bonde AA, et al. Catabolic effect of thyroid hormone excess: The contribution of adrenergic activity to hypermetabolism and protein breakdown. Metabolism 1987; 36: 562-9.
97. Joshi W. Effects of burns on the heart. JAMA 1970; 211: 2130-4.
98. Linares HA. Autopsy findings in burned children. In Pediatric burn management. Carvajal HF, Parks DH eds. 1988. Yearbook Medical Publishers Inc., Chicago, 298-9.
99. Wilmore DW Long JM, Mason AD, Skreen RW, Pruitt BA. Catecholamines: Mediator of the hypermetabolic response to thermal injury. Ann Surg 1974; 180: 653-69.
100. Minifee PK, Barrow RE, Rutan TC, Minifee P, Jahoor F, Wolfe KR. Improved myocardial oxygen utilization following propranolol infusion in adolescents with postburn hypermetabolism. J Pediatr Surg 1989; 24: 806-11.
101. Honeycutt D, Barrow R, Herndon DN. Cold stress response in patients with severe burns after beta-blockade. J Burn Care Rehabil 1992; 13: 181-6.
102. Herndon DN, Nguyen TT, Wolfe RR, et al. Lipolysis in burned patients is stimulated by the beta-2-receptor for catecholamines. Arch Surg 1994; 129: 1301-5.
103. Herndon DN, Wilmore DW, Mason AD, Piutt BA, Humoral mediators of non-temperature dependent hypermetabolism in 50% burned adult rats. Surg Forum 1977; 28: 37-9.
104. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg 1988; 208: 512-23.
105. Daly JM, Lieberman MD, Goldfine J, et al. Enterai nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: Immunologic, metabolic, and clinical outcome. Surgery 1992; 112: 56-67.
106. Alexander JW, MacMillan BG, Stinnett JD, et al. Beneficial effects of aggressive protein feeding in severely burned children. Ann Surg 1980; 192: 505-17.
107. Neely AW, Petra AB, Holloman GH, Rustitan FW, Turner MD, Hardy JD. Researches on the cause of burn hypermetabolism. Ann Surg 1974; 179: 291-4.
108. Madden HP, Breslin RJ, Wasserkrug HL, Efron G, Barbul A. Stimulation of T cell immunity by arginine enhances survival in peritonitis. J Surg Res 1988; 44: 658-63.
109. Saito H, Trocki O, Wang SL, Gonce SS, Joffe SN, Alexander JW. Metabolic and immune effects of dietary arginine supplementation after burn. Arch Surg 1987; 122: 784-9.
110. Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery 1981; 90: 244-51.
111. Kirk SJ, Hurson M, Regan MC, Host DR, Wasserkrug HL, Barbul A. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993; 114: 155-60.
112. Jeffries MK, Vance ML. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil 1992; 13: 391-5.
113. Moller S, Jensen M, Svensson P, Skakkebaek H. Insulin-like growth factor-1 (IGF-1) in burn patients. Burns 1991; 17: 279-81.
114. Abribat T, Brazeau P, Davignon I, Garrel DR. Insulin-like growth factor-1 blood levels in severely burned patients: Effects of time post-injury, age of patient and severity of burn. Clin Endocrinol 1993; 39: 583-9.
115. Rutan RI, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg 1990; 125: 392-5.
116. Gore DC, Honeycutt D, Jahoor F, Wolfe R, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated limb protein kinetics in burned patients. Arch Surg 1991; 126: 38-43.
117. Tanner JM, Hughes CPR, Whitehouse RH. Comparative rapidity of response of height, limb muscle and limb fate to treatment with human growth hormone in patients with and without growth hormone deficiency. Acta Endocrinol 1977; 84: 681-96.
118. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side-effects of prednisone in humans. J Clin Invest 1990; 86: 265-72.
119. Gore DC, Honeycutt D, Jahoor F, Rutan T, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on glucose utilization in burn patients. J Surg Res 1991; 51: 518-23.